Inspections, Compliance, Enforcement, and Criminal Investigations
Marion Health Care Hospital 03-May-02
Department of Health and Human Services
Public Health Service
Baltimore District Office
Inspection ID # 1227950003
May 3, 2002
RETURN RECEIPT REOUESTED
Ms. Carol D. Merrill, Administrator
Marion Health Care Hospital
401 Guffey Street
Fairmont, West Virginia 26554
Dear Ms. Merrill:
A representative from the State of West Virginia, under contract to the Food and Drug Administration (FDA), inspected your facility on February 20, 2002. This inspection revealed a serious regulatory problem involving mammography performed at your facility.
Under a United States Federal law, the Mammography Quality Standards Act (MQSA)
of 1992, [42 U.S.C. 263b], your facility must meet specific requirements for
mammography. These requirements help protect the public health by assuring that
a facility can perform quality mammography. The following finding was listed
on the MQSA Facility Inspection Report provided to you at the close of the inspection.
Your facility failed to document that Phantom QC testing was performed for at least 4 weeks for the [redacted] mammography unit located in the mammography room.
This problem identifies a failure to comply with a significant MQSA requirement
outlined in 21 CFR 900.12(e)(2). This condition may be symptomatic of serious
underlying problems that could compromise the quality of mammography performed
at your facility. It is necessary for you to act on this matter immediately.
Please explain to this office, in writing. within fifteen (15) working days
the date you receive this letter:
The specific steps you have taken to correct the violation noted in this letter.
Each step your facility is taking to prevent the recurrence of similar violations.
Your response should be submitted to: Food and Drug Administration, 6000 Metro Drive, Suite 101 Baltimore, Maryland 21215, to the attention of Steven B. Barber, Compliance Officer.
Finally, you should understand that there are many FDA requirements pertaining
to mammography. This letter pertains only to findings of your inspection and
does not necessarily address other obligations you may have under the law. You
may obtain general information about all of FDAs requirements for mammography
facilities by contacting the Mammography Quality Assurance Program, Food and
Drug Administration, P.O. Box 6057, Columbia, MD 21045-6057 (1-800-838-7715),
or through the Internet
If you have technical questions about mammography facility requirements, or
about the content of this letter, please feel free to contact Elizabeth A. Laudig
at (410) 779-5441.
Director, Baltimore District